tiprankstipranks
Trending News
More News >
Human Metabolome Technologies, Inc. (JP:6090)
:6090
Japanese Market
Advertisement

Human Metabolome Technologies, Inc. (6090) Financial Statements

Compare
0 Followers

Human Metabolome Technologies, Inc. Financial Overview

Human Metabolome Technologies, Inc.'s market cap is currently ¥4.68B. The company's EPS TTM is ¥35.78; its P/E ratio is 14.53; and it has a dividend yield of 1.94%. Human Metabolome Technologies, Inc. is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue¥ 1.35B¥ 1.30B¥ 1.22B¥ 1.12B¥ 1.12B
Gross Profit¥ 869.33M¥ 859.75M¥ 840.00M¥ 806.02M¥ 856.72M
Operating Income¥ 220.17M¥ 210.98M¥ 191.15M¥ 39.37M¥ -17.04M
EBITDA¥ 350.31M¥ 319.65M¥ 329.02M¥ 108.33M¥ 23.84M
Net Income¥ 243.25M¥ 285.76M¥ 267.79M¥ 58.21M¥ -47.79M
Balance Sheet
Cash & Short-Term Investments¥ 1.79B¥ 1.66B¥ 1.50B¥ 1.25B¥ 1.22B
Total Assets¥ 2.60B¥ 2.29B¥ 2.07B¥ 1.62B¥ 1.54B
Total Debt¥ 226.30M¥ 226.52M¥ 233.19M¥ 152.70M¥ 19.73M
Net Debt¥ -1.56B¥ -1.43B¥ -1.27B¥ -1.09B¥ -1.10B
Total Liabilities¥ 656.69M¥ 518.73M¥ 582.15M¥ 363.04M¥ 322.88M
Stockholders' Equity¥ 1.95B¥ 1.77B¥ 1.49B¥ 1.26B¥ 1.22B
Cash Flow
Free Cash Flow¥ 202.70M¥ 168.11M¥ 177.92M¥ -62.04M¥ 149.23M
Operating Cash Flow¥ 236.79M¥ 284.96M¥ 324.03M¥ -34.17M¥ 184.07M
Investing Cash Flow¥ -32.44M¥ -116.75M¥ -152.31M¥ -25.99M¥ -34.94M
Financing Cash Flow¥ -73.15M¥ -13.75M¥ 80.49M¥ 86.22M¥ 22.10M
Currency in JPY

Human Metabolome Technologies, Inc. Earnings and Revenue History

Human Metabolome Technologies, Inc. Debt to Assets

Human Metabolome Technologies, Inc. Cash Flow

Human Metabolome Technologies, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis